AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, and will be replaced by the company’s current president and chief operating officer, Robert Michael.
AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...
Though far from the first large drugmaker to strike a pricing deal with the Trump administration, AbbVie’s new accord is ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
AbbVie has reached a three-year agreement with the Trump administration to reduce drug costs and expand U.S. investment in pharmaceutical development. Under the deal, AbbVie will provide lower prices ...
AbbVie commits to lowering Medicaid drug prices and investing $100 billion in US R&D and capital investments over the next decade. The TrumpRx program will expand direct-to-patient offerings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback